Healthcare utilization and hospital variation in cardiac surveillance during breast cancer treatment: a nationwide prospective study in 5000 Dutch breast cancer patients

Table 4 Concentration of cardiologic healthcare utilization in breast cancer patients in 2013–2015

BC patients with high cardiotoxicity risk (N = 5157)
Type of hospital	Number of hospitals^a (N)	Mean age of treated BC patients (years)	Proportion cardiac surveillance^b (%)	Proportion range (%)	Proportion 5/95 percentile (%)
University hospital	8	53.8	12.2	3.4–23.4	4.2–23.2
Top-clinical hospital	30	54.7	28.6	0.7–96.7	6.2–77.5
General hospital	50	56.2	30.3	7.0–91.7	8.8–59.7

^a6 hospitals were excluded based on small samples (< 30 patients treated) and not delivering cardiac surveillance, ^bProportion of patients treated for BC receiving cardiac surveillance in a hospital. Calculated with the number of patients treated for BC in a hospital and of these patients the number receiving cardiac surveillance

ISSN: 2057-3804